Jerry S. Lanchbury
2018
In 2018, Jerry S. Lanchbury earned a total compensation of $2.4M as Chief Scientific Officer at Myriad Genetics, a 31% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $244,422 |
|---|---|
| Salary | $493,782 |
| Stock Awards | $1,628,500 |
| Other | $10,972 |
| Total | $2,377,676 |
Lanchbury received $1.6M in stock awards, accounting for 68% of the total pay in 2018.
Lanchbury also received $244.4K in non-equity incentive plan, $493.8K in salary and $11K in other compensation.
Rankings
In 2018, Jerry S. Lanchbury's compensation ranked 4,887th out of 14,244 executives tracked by ExecPay. In other words, Lanchbury earned more than 65.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,887 out of 14,244 | 66th |
Division Manufacturing | 1,834 out of 5,765 | 68th |
Major group Chemicals And Allied Products | 670 out of 2,128 | 69th |
Industry group Drugs | 562 out of 1,817 | 69th |
Industry In Vitro and In Vivo Diagnostic Substances | 13 out of 72 | 82nd |
Source: SEC filing on October 10, 2018.
Lanchbury's colleagues
We found four more compensation records of executives who worked with Jerry S. Lanchbury at Myriad Genetics in 2018.